Sep
2012
Vol. 31. No. 3
Perspectives in Atopic Dermatitis-Optimizing Outcomes: Introduction
The faculty members convened for this supplement provide up-to-date evidence that supports some long-held concepts; they also review other recently published data that challenge clinicians to reconsider long-standing ideas about the pathogenesis and treatment of AD.
MORE
Dec
2001
Vol. 20. No. 4
Tacrolimus and Pimecrolimus, Introduction
A challenge in designing this issue of Seminars in Cutaneous Medicine and Surgery was to collect and present a state of the art assessment of our knowledge of these medications for dermatologic use, while acknowledging that our communal experience with them is still fairly limited.
Sep
2012
Vol. 31. No. 3
Atopic Dermatitis: Epidemiology and Pathogenesis Update
Worldwide, the prevalence of atopic dermatitis (AD) has increased approximately threefold since the 1960s.
MORE
Sep
2017
Vol. 36. No. 3
Diagnosis, comorbidity, and psychosocial impact of atopic dermatitis
Understanding both the clinical characteristics and implications of AD is critical to lessening the psychosocial, clinical, and economic burden of this disease.
MORE
Dec
2001
Vol. 20. No. 4
Pathophysiologic Mechanisms in Atopic Dermatitis
This article examines theĀ pathophysiologic mechanisms involved in atopic dermatitis. An understanding of these mechanisms is critical for developing new treatment strategies for this increasingly common illness.